Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NET-PD FS-1: Minocycline and Creatine in Early PD
NCT00063193Phase 2Completed
- Sponsor
- University of Rochester
- Start
- May 2003
- Primary completion
- May 2005
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline, creatine in Parkinson's disease (PD), sponsored by University of Rochester. Started May 2003; status: completed.
02
Drugs
minocyclinecreatine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00063193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063193.